Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 03, 2024.
All times in Eastern Daylight Time.
-
Global Venture Capital Investment Market Analysis 2024-2029 - Alternative Funding Models Reshape Venture Capital Landscape - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Global Venture Capital Investment Market: Analysis By Funding Type, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has... more »
-
MINNEAPOLIS--(BUSINESS WIRE)--Wolters Kluwer Compliance Solutions’ introduction of iLien ResiFixture™ is playing a critical step in helping lenders safeguard their interests for loans associated wi... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 02.05.2024 FEUD IE00BF2FL590 426,732.00 EUR 16,43... more »
-
Floor & Decor Enters New York City Market With First-Ever Flagship at Liberty BklynBROOKLYN, N.Y.--(BUSINESS WIRE)--Floor & Decor has announced its first-ever New York City store, open to the public on May 6, 2024 at 850 3rd Avenue in Brooklyn. more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 02.05.2024 FEUZ IE00B8X9NY41 1,671,193.00 EUR 67,... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 02.05.2024 FEM IE00B8X9NX34 425,002.00 US... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 02.05.2024 FEXD IE00BWTNMB87 582,536.00 ... more »
-
Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory MedicineSAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmon... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
WNS Named a Market Leader in HFS Research First CX Service Providers Horizon ReportNEW YORK & LONDON & MUMBAI, India--(BUSINESS WIRE)--WNS has been recognized as a Market Leader (Horizon 3) in HFS Research’s inaugural HFS Horizons Report: Customer Experience Service Providers, 2024. more »
-
Ventus Therapeutics Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo NordiskWALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing its proprietary structural biology and computational chemistry platform, ... more »
-
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class ... more »
-
New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast CancerAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced a new publication in JCO Precision Oncology reporting on the abili... more »
-
SAN DIEGO--(BUSINESS WIRE)--The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Alphabet Securities Settlement: UNITED STATES DISTRICT COURT NORTHERN DISTR... more »